SCHEMBL31398959

SCHEMBL31398959

C#Cc1c(F)cc2c(nc(C(F)(F)F)n2C)c1F

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.32
▸ GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31398950 0.83 — —
SCHEMBL24463148 0.82 KDM4E (0.33) —
SCHEMBL24463144 0.71 LMNA (0.33) —
SCHEMBL24463425 0.70 KDM4E (0.35) CYP1A2
SCHEMBL24463432 0.70 — —
SCHEMBL24463171 0.68 CTSV (0.33) —
SCHEMBL26790705 0.68 KDM4E (0.31) —
SCHEMBL17378584 0.67 CYP1A2 (0.40) CYP1A2GLA
SCHEMBL24463564 0.66 MAPT (0.38) CYP1A2
SCHEMBL24463121 0.66 ACSS2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119176813-A Tricyclic heterocyclic compound with FGFR inhibition effect, pharmaceutical composition containing tricyclic heterocyclic compound and application of pharmaceutical composition 上海科恩泰生物医药科技有限公司 2024-12-24 — — CN disclosed
Send feedback